You May Also Like

Talk to your doctor about PrEP
Cite
CITE Title : Talk to your doctor about PrEP Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 5/13/2014 URL : https://stacks.cdc.gov/view/cdc/23416
• File Format:
Copy Export
• RIS
[PDF - 467.16 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
5/13/2014
Description:
Are you HIV negative but worry you might become positive? Take charge – talk to your doctor about PrEP.CS247902-A
File Type:
[PDF - 467.16 KB]
File Type:
[PDF - 467.16 KB]

TDF2 study of pre-exposure prophylaxis (PrEP) among heterosexual men and women in Botswana : key facts
Cite
CITE Title : TDF2 study of pre-exposure prophylaxis (PrEP) among heterosexual men and women in Botswana : key facts Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 8/26/11 URL : https://stacks.cdc.gov/view/cdc/23283
• File Format:
Copy Export
• RIS
[PDF - 98.02 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
8/26/11
Description:
Daily oral PrEP with a tablet containing tenofovir disoproxil fumarate and emtricitabine (TDF/FTC, known by the brand name Truvada®) was found to red...
File Type:
[PDF - 98.02 KB]
File Type:
[PDF - 98.02 KB]